BrianBBergerMDboard certified

Ophthalmology • Austin, TX

Retinal Disease, Uveitis

president, Retina Research Center

Join to view full profile

Dr. Berger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berger's full profile

Already have an account?

Office
9707 Anderson Mill Rd Ste 100
Austin, TX 78750
Phone+1 512-279-1251

Fax+1 512-454-5853

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1979 - 1980
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 1976 - 1979
Valleywise HealthInternship, Transitional Year, 1975 - 1976
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975

Certifications & Licensure

TX State Medical License 1981 - 2026
IL State Medical License 1976 - 2014
WI State Medical License 1979 - 1981
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Top Doctors:SE Texas Castle Connolly, 2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
Completed
Phase 2, Phase 3
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
Completed
Phase 3
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
Terminated
Phase 2
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) Start of enrollment: 2013 Feb 01
Completed
Phase 2, Phase 3
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD Start of enrollment: 2015 Jun 01
Terminated
Phase 2
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

17 citations
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
Carl Regillo, Brian Berger, Logan Brooks, W Lloyd Clark, Robert Mittra
Ophthalmology. 2023-07-01
2 citations
Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation.
Connor J Ericksen, Cory A Christensen, Brian Berger, Shamika Gune, Jared S Nielsen
Journal of Vitreoretinal Diseases. 2022-08-04
4 citations
Ranibizumab Injection (Susvimo) Implant Septum Dislodgement in a Patient With Neovascular Age-Related Macular Degeneration.
Kaitlyn Timmons, Luke C Heckmann, Yong Ren, Ivana Gunderson, Fuad Makkouk
JAMA Ophthalmology. 2022-08-01

Journal Articles

A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema
Brian Berger, Douglas Girgenti, Ronald A Schachar, Marla B Sultan, Investigative Ophthalmology and Visual Science

Press Mentions

Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Other Languages

Spanish